GITNUX MARKETDATA REPORT 2024
Companion Diagnostics Industry Statistics
The companion diagnostics industry is expected to continue growing rapidly, driven by increasing demand for personalized medicine and precision therapies.
In this post, we will explore key statistics and trends shaping the companion diagnostics industry. From the dominance of the U.S in the market to the projected growth in Next-generation Sequencing technology and specific therapeutic areas driving demand, these insights offer a comprehensive overview of the current landscape and future prospects in this sector.
Statistic 1
"The U.S accounted for the largest share of the companion diagnostics market in 2020."
Statistic 2
"In terms of technology, Polymerase Chain Reaction-based tests held the largest share of the market in 2021."
Statistic 3
"It is projected that the Next-generation Sequencing (NGS) segment will have the fastest growth during the forecast period."
Statistic 4
"The growth of the market is primarily driven by the increasing demand for targeted therapies."
Statistic 5
"Lung cancer is expected to be the most prominent indication till 2025."
Statistic 6
"The lung cancer segment accounted for more than 30% of the market share in 2019."
Statistic 7
"At the end of 2023, Asia-Pacific companion diagnostics market is predicted to have the 2nd largest share."
Statistic 8
"Roche Diagnostics is the leading company in the global market."
Statistic 9
"The LATAM market is expected to grow from $202M in 2020 to $491M in 2025, at a CAGR of 19.4%."
Statistic 10
"The breast cancer segment was valued at $876M in 2017."
Statistic 11
"By the end of 2026, Immunochemistry testing is predicted to surpass $575M."
Statistic 12
"The global market for Neurological diseases diagnostics is expected to reach $392M by 2026."
Statistic 13
"It's estimated that 79 FDA-approved therapies have at least one approved companion diagnostic."
Statistic 14
"Therapeutic areas like oncology dominate the use of companion diagnostics."
Statistic 15
"As a single country, the US is anticipated to control a 46% share of the market in 2026."
Jannik Lindner
Can You Trust Our Report?
The statistics are checked by us and then entered into the database. Our market data reports have been linked to by some of the largest publishers and companies on the Internet.